Quetiapine sulfoxide dihydrochloride is the primary metabolite of the second-generation antipsychotic Quetiapine. This compound, which acts as a 5-HT receptor agonist and dopamine receptor antagonist, is utilized in pharmacological research to study drug metabolism and receptor interactions in both in vitro and in vivo experimental models.